Phospho-CAMK2B/CAMK2G/CAMK2D (T287) Antibody

Basic Research Questions

• What is the CAMK2 family and what role does T287 phosphorylation play in its function?

  Calcium/calmodulin-dependent protein kinase II (CAMK2) is a key enzyme family involved in calcium signaling that regulates various cellular processes, including synaptic plasticity, muscle contraction, and gene transcription. The family consists of four isozymes (α, β, γ, and δ) encoded by different genes.

  T287 phosphorylation (T286 in CaMKIIα) represents a critical regulatory mechanism that transforms CAMK2 into a calcium-independent or "autonomous" form. When CAMK2 is initially activated by Ca²⁺/calmodulin binding, it can undergo autophosphorylation at T287, which locks the kinase into an activated state even after calcium levels decrease . This molecular switch enables prolonged signaling and is essential for processes like synaptic plasticity and long-term potentiation, fundamentally contributing to learning and memory .

  The significance of T287 phosphorylation is evident in structural studies that show how this modification prevents the regulatory domain from inhibiting the catalytic domain, thereby sustaining kinase activity in the absence of Ca²⁺/calmodulin .

• What applications are validated for Phospho-CAMK2B/CAMK2G/CAMK2D (T287) Antibody?

  The Phospho-CAMK2B/CAMK2G/CAMK2D (T287) Antibody has been validated for multiple research applications:

  • Western Blot (WB): For detection of phosphorylated CAMK2 isoforms at approximately 50-60 kDa

  • Immunohistochemistry (IHC): For tissue section analysis at dilutions of 1:100-1:300

  • Immunofluorescence (IF/ICC): For cellular localization studies at dilutions of 1:50-200

  • ELISA: For quantitative analysis of phosphorylated CAMK2 levels

  Western blotting is the most commonly reported application, where researchers can observe distinct bands at approximately 60kD, 55kD, and 51kD, representing different CAMK2 variants . The antibody demonstrates high specificity for the phosphorylated form, as confirmed by phosphatase treatment controls that eliminate immunolabeling .

• How should samples be prepared for optimal phospho-CAMK2 detection?

  Optimal sample preparation is critical for reliable phospho-CAMK2 detection:

  1. Quick freezing after stimulation: Samples should be quick-frozen immediately after stimulation to preserve phosphorylation states .

  2. Phosphatase inhibitors: Include phosphatase inhibitors in all buffers to prevent dephosphorylation during sample preparation .

  3. Protein extraction: For tissue samples, homogenization in buffer containing protease and phosphatase inhibitors is recommended.

  4. SDS-PAGE conditions: Samples should be separated using SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes for optimal results .

  5. Protein loading verification: Confirm protein matching between samples by staining membranes with napthol blue black and measuring actin band densitometry .

  6. Secondary detection: Enhanced chemiluminescence or infrared imaging systems can be used for detection, with secondary antibodies conjugated with HRP or infrared dyes (typically used at 1:1000 dilution) .

• What controls should be included when using phospho-specific CAMK2 antibodies?

  Proper controls are essential when working with phospho-specific antibodies:

  1. Phosphatase treatment: Lambda phosphatase (λ-PPase) treatment of a portion of your samples can serve as a negative control. This enzymatically removes phosphate groups, demonstrating the phospho-specificity of the antibody .

  2. Stimulation controls: Include both stimulated (e.g., with Ca²⁺ or activators) and unstimulated samples to demonstrate signal specificity to activation conditions .

  3. Knockout/knockdown samples: If available, include samples from CAMK2 knockout or knockdown experiments as specificity controls .

  4. Peptide competition: Including a peptide derived from the phosphorylation site region can validate binding specificity .

  5. Cross-reactivity testing: When possible, test against recombinant proteins of different CAMK2 isoforms to confirm specificity .

Advanced Research Questions

• How can I distinguish between different CAMK2 isoforms when using this phospho-specific antibody?

  Distinguishing between different CAMK2 isoforms requires careful experimental design:

  1. Molecular weight differentiation: The different isoforms can be distinguished by their molecular weights on Western blots. Based on published data, the major bands typically resolve as follows :

     • ~60 kDa: CAMK2G variants G1 & G2

     • ~55 kDa: CAMK2B & CAMK2J variants

     • ~51 kDa: CAMK2C variants C1 & C2

     • ~50 kDa: CAMK2A (alpha) subunit

  2. Pre-immunoprecipitation: For more definitive identification, consider pre-immunoprecipitation with isoform-specific total CAMK2 antibodies before detection with the phospho-specific antibody.

  3. Recombinant protein standards: Include purified recombinant proteins of each isoform as standards on your gels for precise molecular weight comparison .

  4. Sequential immunoblotting: Strip and reprobe membranes with isoform-specific CAMK2 antibodies to confirm the identity of bands detected with the phospho-antibody.

  5. Tissue-specific expression patterns: Leverage the known differential expression patterns of CAMK2 isoforms in different tissues (e.g., CAMK2A is highly enriched in brain tissue) .

• What approaches can be used to study the temporal dynamics of T287 phosphorylation in response to stimuli?

  Studying temporal dynamics of T287 phosphorylation requires time-resolved measurements:

  1. Time-course experiments: Design experiments with multiple time points after stimulation to capture the progression of phosphorylation. In published studies, researchers have observed distinct phosphorylation patterns at different timepoints following stimulation with agents like PE (phenylephrine) or KCl .

  2. Quantitative Western blotting: Use quantitative densitometry to measure phosphorylation levels across time points. Modern infrared imaging systems (e.g., LI-COR Odyssey) provide excellent quantitative data for phospho-protein analysis .

  3. Phosphoproteomics: For high-throughput analysis, consider TMT (Tandem Mass Tag) labeling-based phosphoproteomics, which allows comparison of phosphorylation states between different conditions and time points .

  4. Live-cell imaging: For cellular studies, phospho-specific antibodies can be adapted for immunofluorescence to track subcellular localization changes of phosphorylated CAMK2 over time.

  5. In vitro kinase assays: Complement antibody-based detection with in vitro kinase assays to correlate phosphorylation with enzymatic activity changes over time .

  Research has shown that different CAMK2 variants may exhibit distinct temporal phosphorylation patterns, with some showing peak phosphorylation at different time points after stimulation .

• How does CAMK2 T287 phosphorylation contribute to neuronal plasticity, and how can this be studied experimentally?

  CAMK2 T287 phosphorylation is a critical molecular switch in neuronal plasticity:

  1. Mechanistic role: T287 phosphorylation converts CAMK2 to a calcium-independent form, enabling sustained activity that underlies synaptic plasticity. This prolonged activity is essential for long-term potentiation (LTP), a key mechanism for learning and memory .

  2. Experimental approaches:

     • Electrophysiology with molecular interventions: Combine patch-clamp recordings with phospho-specific antibody injection or phospho-mimetic mutations to correlate T287 phosphorylation with synaptic strength changes.

     • Genetic models: Utilize mouse models with mutations affecting CAMK2 T287 phosphorylation. Recent gene knockout studies show that CAMK2A and CAMK2B can have distinct roles yet also partially compensate for each other .

     • Phosphoproteomics of synaptic fractions: Analyze phosphorylation changes in synaptic protein fractions following LTP induction to identify downstream targets of activated CAMK2 .

     • High-resolution imaging: Employ super-resolution microscopy with phospho-specific antibodies to visualize the spatial distribution of activated CAMK2 at synapses during plasticity events.

  3. Important findings: Research has shown that T287 phosphorylation alone does not directly contribute to tone maintenance, but the combined effect with other regulatory mechanisms like T305 phosphorylation regulates history-dependent increases in synaptic function .

• What methodological considerations are important when using Phospho-CAMK2 (T287) antibodies in brain tissue analysis?

  Brain tissue analysis requires special considerations:

  1. Rapid tissue processing: The brain contains high levels of phosphatases that can rapidly dephosphorylate proteins. Flash-freezing tissue immediately after dissection is critical .

  2. Phosphatase inhibition: Include multiple phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) in all buffers during tissue processing .

  3. Fixation for IHC/IF: For immunohistochemistry, optimize fixation protocols as overfixation can mask phospho-epitopes. Generally, 4% paraformaldehyde for 24 hours followed by optimal antigen retrieval is recommended .

  4. Region-specific analysis: Different brain regions express varying levels of CAMK2 isoforms. In rat brain tissue lysates, Western blots have demonstrated specific immunolabeling of the ~50 kDa alpha-CaMKII subunit phosphorylated at T286 and the ~60 kDa beta-CaMKII subunit phosphorylated at T287 .

  5. Signal validation: Lambda phosphatase treatment of brain lysates provides an excellent negative control, as demonstrated in studies showing complete elimination of immunolabeling after phosphatase treatment .

  6. Co-localization studies: Consider dual labeling with markers for specific neuronal populations or subcellular compartments to provide context for phospho-CAMK2 signals.

• How can Phospho-CAMK2B/CAMK2G/CAMK2D (T287) Antibody be used to investigate disease models?

  This antibody serves as a valuable tool for investigating disease mechanisms:

  1. Neurodegenerative disorders: Changes in CAMK2 phosphorylation have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The antibody can be used to track disease-related alterations in CAMK2 activation in animal models or human postmortem tissue .

  2. Cardiovascular diseases: CAMK2D regulates calcium handling in cardiac cells, with aberrant activation linked to heart failure and arrhythmias. Phospho-specific antibodies allow quantification of disease-related changes in CAMK2 activity .

  3. Cancer biology: CAMK2 signaling affects cell proliferation and survival pathways relevant to cancer. The antibody can be used to evaluate CAMK2 activation in tumor samples and cancer cell lines .

  4. Developmental disorders: Given CAMK2's role in neurodevelopment, the antibody can be used to assess phosphorylation changes in models of developmental disorders. Recent research has elucidated CAMK2D's role in neurodevelopment and associated conditions .

  5. Methodological approaches:

     • Compare phospho-CAMK2 levels between diseased and control samples via Western blotting or IHC

     • Correlate phosphorylation changes with disease progression markers

     • Evaluate therapeutic interventions targeting CAMK2 signaling by monitoring T287 phosphorylation

     • Combine with phosphoproteomic analyses to identify disease-related changes in CAMK2 substrates

• What are the considerations when studying CAMK2 substrate specificity using phosphoproteomics approaches?

  Phosphoproteomics provides powerful insights into CAMK2 substrate networks:

  1. Experimental design strategies:

     • Genetic models: Utilize CAMK2 knockout or knockdown approaches. Phosphoproteomic analyses on tissue from inducible Camk2a and Camk2b double knockout (Camk2a^f/f;Camk2b^f/f;CAG-CreESR) mice compared to wild type can reveal endogenous substrates .

     • In vitro phosphorylation: Complement in vivo studies with in vitro kinase assays using purified CAMK2 and candidate substrates .

     • Pharmacological approaches: Use selective CAMK2 inhibitors (e.g., KN93) with appropriate controls (KN92) to identify phosphorylation events dependent on CAMK2 activity .

  2. Key findings from recent phosphoproteomics studies:

     • A recent study identified 130 proteins with downregulated phosphorylation in CAMK2A/B double knockout mice, including 113 proteins not previously identified as CAMK2 substrates .

     • Analysis of phosphorylation sites revealed a consensus motif for CAMK2-dependent phosphorylation consisting of: -5 hydrophobic, -3 basic, +1 hydrophobic and +2 acidic amino acid, with the phosphorylated residue at position 0 .

     • The position at +2 has a conditional effect that is substrate-specific, substantially increasing catalytic efficiency for some substrates while having minimal effect on others .

  3. Technical considerations:

     • Use TMT (Tandem Mass Tag) labeling for quantitative comparison between conditions .

     • Include appropriate controls such as phosphatase-treated samples .

     • Consider subcellular fractionation to enrich for compartment-specific CAMK2 substrates.

     • For interpreting results, cross-reference with the established CAMK2 consensus motif while recognizing that variations may exist for specific substrates .

• How do different stimulation conditions affect CAMK2 T287 phosphorylation and what is the significance for experimental design?

  Stimulation conditions dramatically impact phosphorylation outcomes:

  1. Common stimulation approaches and their effects:

     • Calcium influx stimuli: KCl depolarization, glutamate receptor activation, or calcium ionophores induce rapid T287 phosphorylation .

     • Receptor-mediated stimulation: Agents like phenylephrine (PE) can trigger CAMK2 phosphorylation through receptor-activated calcium pathways .

     • Frequency-dependent responses: CAMK2 shows distinct phosphorylation patterns in response to different frequencies of stimulation, with studies showing that alternative splicing modulates these frequency-dependent responses .

  2. Experimental design considerations:

     • Stimulus intensity and duration: Titrate stimulus concentration and exposure time to capture the full dynamic range of phosphorylation.

     • Temporal resolution: Include multiple time points (seconds to minutes) to capture phosphorylation dynamics .

     • Isoform-specific responses: Different CAMK2 isoforms may show varied phosphorylation kinetics and magnitudes in response to the same stimulus .

     • Analytical methods: Consider both qualitative (presence/absence of phosphorylation) and quantitative (degree of phosphorylation) analyses.

  3. Physiological significance:

     • The frequency-dependence of CAMK2 activation is thought to be a key mechanism by which neurons decode calcium oscillations into distinct physiological responses .

     • Studies have shown that β-CaMKII splice variants (β, βM, and βe') have similar Ca²⁺/CaM-stimulated specific activities and can become highly Ca²⁺-independent after T287 autophosphorylation induced by prolonged Ca²⁺/CaM stimulation .

• What are the emerging techniques for studying CAMK2 T287 phosphorylation in live cells or tissues?

  Emerging techniques offer new possibilities for dynamic studies:

  1. Genetically encoded biosensors:

     • Design FRET-based sensors that report on CAMK2 conformational changes associated with T287 phosphorylation.

     • These sensors can monitor CAMK2 activation in real-time within living cells.

  2. Phospho-specific nanobodies:

     • Develop nanobodies that specifically recognize phosphorylated T287.

     • When fused to fluorescent proteins, these can be expressed in cells to report on endogenous CAMK2 phosphorylation events.

  3. Mass spectrometry imaging:

     • Apply advanced mass spectrometry imaging techniques to visualize phosphorylation patterns across tissue sections with high spatial resolution.

  4. CRISPR-based approaches:

     • Recent advances have utilized CRISPR/Cas9 to introduce specific mutations affecting CAMK2 phosphorylation or splicing.

     • A study introduced a weaker, human branch point sequence into the mouse genome, resulting in strongly altered Camk2b splicing in mouse brains, demonstrating the impact on long-term potentiation in CA3-CA1 synapses .

  5. Phosphoproteomics combined with proximity labeling:

     • Combine BioID or APEX2 proximity labeling with phosphoproteomics to identify substrates phosphorylated by CAMK2 in specific subcellular compartments.

  6. Single-molecule imaging:

     • Apply super-resolution microscopy with phospho-specific antibodies to visualize individual phosphorylated CAMK2 molecules in situ.

     • This provides insights into spatial distribution and clustering of activated CAMK2.

Technical Considerations

• How do I troubleshoot weak or inconsistent signals when using Phospho-CAMK2B/CAMK2G/CAMK2D (T287) Antibody?

  Troubleshooting requires systematic evaluation of each experimental step:

  1. Sample preparation issues:

     • Phosphatase activity: Ensure complete phosphatase inhibition throughout sample preparation. Include multiple inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) .

     • Degradation: Minimize time between tissue/cell collection and protein extraction. Use ice-cold buffers and work quickly.

     • Stimulation conditions: Verify that your stimulation protocol effectively activates CAMK2. Consider positive controls with known stimulators.

  2. Technical considerations:

     • Antibody dilution: Optimize antibody concentration. Recommended dilutions are 1:500-1:2000 for WB, 1:100-1:300 for IHC .

     • Incubation conditions: Extend primary antibody incubation time (overnight at 4°C may improve signal).

     • Detection system: Try alternative detection methods (chemiluminescence vs. infrared imaging) .

     • Membrane type: PVDF membranes are often preferred for phospho-protein detection .

     • Blocking conditions: Excessive blocking can mask epitopes; optimize blocking agent concentration and duration.

  3. Verification approaches:

     • Positive controls: Include samples with known high levels of phosphorylated CAMK2 (e.g., brain tissue lysates) .

     • Phosphatase treatment: Split your sample and treat half with lambda phosphatase to confirm signal specificity .

     • Alternative antibody: Try a different phospho-CAMK2 antibody to confirm results.

     • Antibody validation: Verify antibody activity using dot blots with phosphorylated and non-phosphorylated peptides.

• What are the considerations for quantitative analysis of CAMK2 phosphorylation across experimental conditions?

  Quantitative analysis requires careful experimental design and controls:

  1. Normalization strategies:

     • Total protein normalization: Use total protein stains (e.g., REVERT, Ponceau S) rather than single housekeeping proteins.

     • Phospho-to-total ratio: Normalize phospho-CAMK2 signal to total CAMK2 from the same samples to account for expression differences .

     • Internal standards: Consider including a constant amount of a standard phosphoprotein in all samples as an internal control.

  2. Technical approaches:

     • Multiplex detection: Use dual-color infrared imaging systems to simultaneously detect phospho-CAMK2 and total CAMK2 on the same blot .

     • Dynamic range considerations: Ensure detection is within the linear range of your imaging system.

     • Replication: Include biological and technical replicates to assess variability.

     • Quantitative phosphoproteomics: For comprehensive analysis, consider TMT-based quantitative phosphoproteomics which allows accurate comparison between conditions .

  3. Statistical analysis:

     • Apply appropriate statistical tests based on your experimental design.

     • Report both absolute and relative changes in phosphorylation.

     • Consider the biological significance of quantitative changes (fold-changes vs. percent changes).

  4. Considerations for multiple phosphorylation sites:

     • CAMK2 has multiple regulatory phosphorylation sites (T286/287, T305/306, T306/307, S275, T333) .

     • Different phosphorylation sites may show distinct dynamics and regulation.

     • Consider monitoring multiple phosphorylation sites simultaneously to gain a complete picture of CAMK2 regulation.